Every Form 4 that Cadre Holdings, Inc. (CDRE) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CDRE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CDRE filings page.
Cadre Holdings, Inc. (CDRE) reported insider transactions by CEO, Chairman and >10% owner Warren B. Kanders. Through Kanders SAF, LLC, he sold 200,000 shares of Common Stock on August 24–25, 2026 in open-market transactions at weighted average prices ranging from $31.54 to $33.65 per share. After these sales, Kanders SAF, LLC held 9,551,608 shares indirectly, while additional positions reported include 22,888 shares held directly, 1,305,650 shares held through a Warren B. Kanders Roth IRA, and 23,450 shares held through an Allison Kanders Roth IRA. The reporting person is the sole manager and member of Kanders SAF, LLC and disclaims beneficial ownership of certain securities except to the extent of his pecuniary interest.
Cadre Holdings, Inc. (CDRE) reported that its President, Brad Williams, exercised stock options and sold shares on August 17, 2026. He exercised options covering 88,742 shares of Common Stock at exercise prices of $23.45 and $20.53 per share under the company’s 2021 Stock Incentive Plan. The transactions resulted in the acquisition of 42,770 and 45,972 shares of Common Stock, with 107,851 shares reported as directly owned immediately after one of the exercises. On the same date he sold a total of 88,742 shares of Common Stock in open-market transactions at weighted average prices of $34.34 (range $34.25–$34.38) and $33.24 (range $33.02–$33.66) per share. The filing indicates these trades were not made pursuant to a Rule 10b5-1 trading plan.
Cadre Holdings, Inc. insider Warren B. Kanders, through affiliated entity Kanders SAF, LLC, reported open-market sales of a total of 75,000 shares of Common Stock. On June 18, Kanders SAF, LLC sold 25,000 shares at a weighted average price of $27.86 per share, in multiple trades within a $27.49–$28.42 range. On June 22, it sold an additional 50,000 shares at a weighted average price of $27.43 per share, with individual trades between $27.28–$27.67. Following these transactions, Kanders SAF, LLC held 9,667,039 shares after the June 18 sale and 9,617,039 shares after the June 22 sale, indicating the sales were a small portion of the reported indirect position. Separate holding entries show 1,305,650 shares held by a Warren B. Kanders Roth IRA, 23,450 shares held by an Allison Kanders Roth IRA, and 22,888 shares held directly, all as of June 18. Footnotes state Kanders is the sole manager and member of Kanders SAF, LLC and that he disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.
Cadre Holdings, Inc. director Mary E. Kissel received a grant of stock options for 17,393 shares of common stock. The options have an exercise price of $28.75 per share and expire on June 16, 2036, functioning as equity-based compensation rather than an open-market purchase.
These options were granted under the company’s 2021 Stock Incentive Plan. They vest in four installments: 4,349 shares on June 30, 2026, and 4,348 shares on each of September 30, 2026, December 31, 2026, and March 31, 2027. All holdings reported are direct.
Cadre Holdings director William G. Quigley III received a grant of stock options for 17,393 shares of common stock at an exercise price of $28.75 per share. The options were granted under Cadre’s 2021 Stock Incentive Plan as equity-based compensation.
These options vest in four installments: options to purchase 4,349 shares vest and become exercisable on June 30, 2026, and options to purchase 4,348 shares vest and become exercisable on each of September 30, 2026, December 31, 2026, and March 31, 2027. Any unexercised options expire on June 16, 2036.
Cadre Holdings, Inc. reported that director Hamish Norton received a grant of stock options to purchase 17,393 shares of common stock at an exercise price of $28.75 per share under the company’s 2021 Stock Incentive Plan. The options expire on June 16, 2036 and vest in four installments between June 30, 2026 and March 31, 2027.
Cadre Holdings director Nicolas Sokolow received a grant of stock options to buy 17,393 shares of common stock at an exercise price of $28.75 per share. These options expire on June 16, 2036 and were issued under the company’s 2021 Stock Incentive Plan.
According to the vesting schedule, options for 4,349 shares will vest and become exercisable on June 30, 2026. Additional tranches of 4,348 options will vest and become exercisable on each of September 30, 2026, December 31, 2026, and March 31, 2027.
Cadre Holdings, Inc. reported new equity awards for its Chief Financial Officer, Blaine Browers. He received stock options for 115,000 and 92,500 shares of common stock at an exercise price of $28.75 per share, along with restricted stock unit awards covering 69,500 and 48,500 shares.
All four grants are performance-based. The RSUs vest only if the common stock reaches a volume-weighted average price of at least $60.00 or $80.00 per share, depending on the tranche, over a 20 consecutive trading day period on or before June 16, 2033, and then only after the third anniversary of grant. The options have similar VWAP hurdles of $60.00 and $80.00 per share and become exercisable on the later of meeting those conditions and the third anniversary.
Cadre Holdings, Inc. reported that President Brad Williams received new equity awards tied to future stock performance. On June 16, 2026, he was granted stock options for 136,000 and 109,500 shares of common stock at an exercise price of $28.75 per share, expiring on June 16, 2033. He also received 82,000 and 57,500 restricted stock units. All four awards vest only if, on or before June 16, 2033, Cadre’s stock reaches a volume-weighted average price of at least $60 or $80 per share over 20 consecutive trading days, and then only after at least three years have passed from the grant date.
Cadre Holdings CEO and chairman Warren B. Kanders received significant performance-based equity awards in the form of stock options and restricted stock units. On the reported date, he was granted options to purchase 496,500 and 616,500 shares of common stock at an exercise price of $28.75 per share, and 261,000 and 373,000 restricted stock units.
All awards vest only if, on or before June 16, 2033, Cadre’s stock reaches specified volume-weighted average price targets of $60 or $80 per share over a 20-day period. These are compensation grants, not open-market share purchases or sales.
Cadre Holdings, Inc. director, CEO and chairman Warren B. Kanders reported that Kanders SAF, LLC, an entity he manages, sold a total of 225,000 shares of Cadre common stock in open-market transactions on June 15–17, 2026.
The LLC sold 100,000 shares at a weighted average price of $30.03 on June 15, 100,000 shares at $28.19 on June 16, and 25,000 shares at $28.68 on June 17, across multiple trades each day. After these sales, Kanders SAF, LLC held 9,692,039 shares of Cadre common stock.
The filing also lists other indirect holdings, including 1,305,650 shares held by a Roth IRA for Warren B. Kanders and 23,450 shares held by a Roth IRA for his spouse, plus 22,888 shares held directly. Kanders disclaims beneficial ownership of certain securities except to the extent of his pecuniary interest.
Cadre Holdings, Inc. president Brad Williams received new equity awards as part of his compensation. He was granted 18,399 restricted stock units tied to Cadre common stock, which will vest in three equal installments of 6,133 shares on March 30 of 2027, 2028, and 2029.
Williams also received stock options for 59,597 shares at an exercise price of $29.39 per share, expiring on March 30, 2036. These options vest in three tranches: 19,867 shares on March 30, 2027, and 19,865 shares on each of March 30, 2028 and 2029.
Cadre Holdings, Inc. granted CEO and Chairman Warren B. Kanders new equity awards as part of his compensation. He received 44,684 restricted stock units tied to the company’s common stock.
According to the award terms, 14,896 RSUs will vest on March 30, 2027, and 14,894 RSUs will vest on each of March 30, 2028, and March 30, 2029. He was also granted options on 144,735 shares at a $29.39 exercise price, which vest in three equal installments on March 30 of 2027, 2028, and 2029 and expire on March 30, 2036.
Cadre Holdings, Inc. granted equity awards to its Chief Financial Officer, Blaine Browers. He received 15,333 restricted stock units tied to Cadre common stock, which will vest in three equal installments of 5,111 shares on March 30 of 2027, 2028, and 2029. He was also granted stock options for 49,664 shares at an exercise price of $29.39 per share, expiring on March 30, 2036, with one-third becoming exercisable on each of March 30, 2027, 2028, and 2029. These awards are part of the company’s 2021 Stock Incentive Plan and represent compensation, not open-market buying or selling.
Cadre Holdings, Inc. director, CEO and chairman Warren B. Kanders reported open-market sales of Common Stock through an affiliated entity. Kanders SAF, LLC sold 100,000 shares on March 20 at a weighted average price of $31.40 per share and another 100,000 shares on March 23 at a weighted average price of $31.93 per share, each executed across multiple trades within stated price ranges. After these sales, Kanders SAF, LLC held 9,917,039 shares, while Warren B. Kanders also reported 22,888 shares held directly, 1,305,650 shares held through his Roth IRA and 23,450 shares held through his spouse’s Roth IRA, and he disclaimed beneficial ownership beyond his pecuniary interest in these securities.
Cadre Holdings president Brad Williams exercised vested equity awards and had shares withheld for taxes. On March 18, 2026, 4,508 restricted stock units from a 2024 grant converted into 4,508 shares of common stock at a $0.00 exercise price. To cover tax obligations from this vesting, 1,098 common shares were withheld by the company at $32.22 per share, leaving Williams with 65,081 common shares held directly after the transactions. The original 2024 restricted stock unit award covered 13,524 shares of common stock, with 4,508 shares vesting on each of March 18, 2025 and March 18, 2026, and a remaining 4,508 scheduled to vest on March 18, 2027.
Cadre Holdings, Inc. chief financial officer Blaine Browers reported routine equity compensation activity. On March 18, 2026, 3,282 restricted stock units from a March 18, 2024 award vested into an equal number of shares of common stock. To cover tax withholding on this vesting, 1,292 shares of common stock were withheld by the company at a price of $32.22 per share rather than sold on the open market. After these transactions, Browers directly holds 69,653 shares of Cadre common stock. The underlying restricted stock unit award originally covered 9,846 shares and continues to vest in annual installments through March 18, 2027.
Cadre Holdings CEO Warren B. Kanders reported routine equity compensation activity. On March 18, 2026, 11,180 restricted stock units granted in 2024 converted into an equal number of Cadre Holdings common shares. To cover tax obligations from this vesting, 4,400 common shares were withheld by the company at a price of $32.22 per share.
Following these transactions, Kanders holds 22,888 shares of common stock directly. He also reports additional indirect holdings, including shares held by Kanders SAF, LLC and by Roth IRAs for himself and his spouse, while disclaiming beneficial ownership except to the extent of his pecuniary interest.
Cadre Holdings, Inc. president Brad Williams reported routine equity compensation activity tied to restricted stock units vesting on March 13, 2026. He exercised RSUs covering 4,191 and 5,170 shares of common stock, creating 9,361 new shares.
To cover tax obligations from these vestings, the issuer withheld 1,021 and 1,388 shares at a price of $31.65 per share, for a total of 2,409 shares withheld. After these exercises and tax-withholding dispositions, Williams directly owns 61,671 shares of Cadre Holdings common stock.
Cadre Holdings, Inc. Chief Financial Officer Blaine Browers reported compensation-related equity activity tied to restricted stock units that vested on March 13, 2026. He exercised awards covering 7,702 shares of Common Stock at a conversion price of $0.00 per share, reflecting RSU vesting rather than an open-market purchase.
To cover tax obligations from these vestings, the company withheld a total of 3,181 shares of Common Stock at $31.65 per share, reported as tax-withholding dispositions rather than sales into the market. Following these transactions, Browers directly owns 67,663 shares of Cadre Holdings Common Stock.
Cadre Holdings CEO Warren B. Kanders reported routine equity compensation activity. Restricted stock units granted under the company’s stock plan vested on March 13, 2026, converting into 24,011 shares of Common Stock through two exercises coded "M".
The company withheld 9,449 shares of Common Stock at $31.65 per share (codes "F") to cover related tax obligations, leaving the remaining vested shares as additional direct holdings. The filing also shows large indirect Common Stock positions held through entities associated with Kanders, including 10,117,039 shares by Kanders SAF, LLC, 1,305,650 shares by a Warren B. Kanders Roth IRA, and 23,450 shares by an Allison Kanders Roth IRA, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
Cadre Holdings, Inc. insider Warren B. Kanders, who serves as CEO, Chairman, director and a 10% owner, reported a charitable stock gift. On 12/24/2025, he transferred 12,250 shares of Cadre common stock as a gift at a reported price of $0, moving the shares from his indirect holdings through Kanders SAF, LLC to a qualified charitable organization.
After this transaction, Kanders reported indirect beneficial ownership of 10,117,039 shares through Kanders SAF, LLC, as well as additional indirect holdings of 1,305,650 shares through a Warren B. Kanders Roth IRA and 23,450 shares through an Allison Kanders Roth IRA. He disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.
Cadre Holdings' chief financial officer Blaine Browers reported selling 20,435 shares of common stock on 12/12/2025 at a weighted average price of $43.79 per share. After this transaction, he directly beneficially owned 63,142 shares of Cadre Holdings common stock.
The sale was reported as a single transaction in the filing, with shares sold in multiple trades at prices ranging from $43.41 to $44.31 per share.
Cadre Holdings, Inc. president Brad Williams reported a sale of company stock. On 12/10/2025, he sold 24,000 shares of Cadre Holdings common stock in an open-market transaction. The weighted average sale price was $42.99 per share, with individual trades executed between $41.84 and $43.39 per share. After this transaction, Williams beneficially owns 54,719 shares of Cadre Holdings common stock, held directly.
Cadre Holdings, Inc. (CDRE) CEO and Chairman Warren B. Kanders reported significant stock sales. On 11/17/2025, he sold 1,257,038 shares of Cadre common stock at $39 per share in a direct transaction, leaving him with 1,546 directly held shares. He also reported an indirect sale of 86,903 shares at $39 per share through Kanders SAF, LLC, after which that entity held 10,129,289 shares indirectly for him.
In addition, Kanders reported indirect beneficial ownership of 1,305,650 shares held in the Warren B. Kanders Roth IRA and 23,450 shares held in the Allison Kanders Roth IRA. He is listed as a director, 10% owner, and CEO and Chairman, and disclaims beneficial ownership of certain indirect holdings except to the extent of his pecuniary interest.
Cadre Holdings, Inc. (CDRE) reported an insider stock sale by its President. According to the filing, the officer sold 27,370 shares of common stock on 11/13/2025 in an open-market transaction coded "S" (sale) at a weighted average price of $43.62 per share.
After this transaction, the reporting person beneficially owned 78,719 shares of Cadre Holdings common stock. The shares were sold in multiple trades within a price range of $43.50 to $43.82 per share, and detailed trade-by-trade information is available upon request as noted in the footnote.
Cadre Holdings (CDRE): CEO and Chairman Warren B. Kanders reported the vesting and settlement of a previously granted restricted stock units award. On November 10, 2025, 2,000,000 restricted stock units vested and were converted into Common Stock. To cover tax obligations from this vesting, the issuer withheld 787,000 shares at $43.32 per share, leaving Kanders with 1,258,584 shares held directly.
Kanders also reports indirect holdings of 10,216,192 shares through Kanders SAF, LLC, 1,305,650 shares through the Warren B. Kanders Roth IRA, and 23,450 shares through the Allison Kanders Roth IRA. He is listed as Director, 10% Owner, and Officer (CEO and Chairman).
Cadre Holdings, Inc. (CDRE) reported an insider transaction on Form 4. The company’s President sold 4,132 shares of common stock at $43 on 10/24/2025.
Following the sale, the reporting person directly owns 106,089 shares. The filing notes the transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 14, 2025.
Cadre Holdings (CDRE) filed a Form 4 showing an officer sale. On 10/14/2025, the company’s President sold 4,132 shares of Common Stock at $40 per share, coded “S.” The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 14, 2025. Following the sale, the officer beneficially owns 110,221 shares directly.